Laforova nemoc [Lafora Disease]

tematický
1
Termíny

nemoc Laforových tělísek s pozdním nástupem
progresivní myoklonická epilepsie Laforova typu

 

Epilepsy Progressive Myoclonic 2
Epilepsy, Progressive Myoclonic 2A
Epilepsy, Progressive Myoclonic, Lafora
Lafora Body Disease
Lafora Body Disease, Late Onset
Lafora Body Disorder
Lafora Progressive Myoclonic Epilepsy
Lafora Progressive Myoclonus Epilepsy
Lafora Type Progressive Myoclonic Epilepsy
Lafora-Body Disease, Late Onset
Late Onset Lafora Body Disease
Myoclonic Epilepsy of Lafora
Progressive Myoclonic Epilepsy Type 2
Progressive Myoclonic Epilepsy, Lafora
Progressive Myoclonic Epilepsy, Lafora Type
Progressive Myoclonus Epilepsy, Lafora Type

Perzistentní odkaz   https://www.medvik.cz/link/D020192
Definice

Myoklonická epilepsie s autozomálně recesivní dědičností (dále demence, slepota aj.). V nervových buňkách se objevují mukopolysacharidové inkluze (Laforova tělíska) asi v důsledku enzymového defektu metabolismu polysacharidů. (cit. Velký lékařský slovník online, 2018 http://lekarske.slovniky.cz)

A form of stimulus sensitive MYOCLONIC EPILEPSY inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid (Lafora) bodies are found in neurons, liver, skin, bone, and muscle (From Menkes, Textbook of Childhood Neurology, 5th ed, pp111-110).

DUI
D020192 MeSH Prohlížeč
CUI
M0328685
Předchozí užití
Epilepsy (1966-1976); Epilepsies, Myoclonic (1977-1999)
Historická pozn.
2000; use Epilepsy, Myoclonic 1977-1999
Veřejná pozn.
2000; see Epilepsy, Myoclonic 1977-1999

C Nemoci
C10.228.140 nemoci mozku 1 177
C10.228.140.490 epilepsie 3 247
C10.228.140.490.375 epilepsie generalizovaná 58
C10.228.140.490.375.130 epilepsie myoklonické 45
C10.228.140.490.375.130.650 myoklonické epilepsie progresivní 10
C10.228.140.490.375.130.650.500 Laforova nemoc 1
C10.228.140.490.375.130.650.700 syndrom MERRF 4
C10.228.140.490.375.130.650.900 Unverrichtův-Lundborgův syndrom 1
C10.228.140.490.493 epileptické syndromy 19
C10.228.140.490.493.063 epilepsie myoklonické 45
C10.228.140.490.493.063.650 myoklonické epilepsie progresivní 10
C10.228.140.490.493.063.650.500 Laforova nemoc 1
C10.228.140.490.493.063.650.700 syndrom MERRF 4
C10.228.140.490.493.063.650.900 Unverrichtův-Lundborgův syndrom 1
C10.574.500.024 Alexanderova nemoc 6
C10.574.500.300 syndrom Canavanové 9
C10.574.500.362 Cockayneův syndrom 4
C10.574.500.497 Huntingtonova nemoc 322
C10.574.500.529 Laforova nemoc 1
C10.574.500.545 myotonia congenita 17
C10.574.500.547 myotonická dystrofie 94
C10.574.500.549 neurofibromatózy 28
C10.574.500.850 Tourettův syndrom 86
C10.574.500.865 tuberózní skleróza 141
C16.320.400.024 Alexanderova nemoc 6
C16.320.400.150 syndrom Canavanové 9
C16.320.400.200 Cockayneův syndrom 4
C16.320.400.430 Huntingtonova nemoc 322
C16.320.400.480 Laforova nemoc 1
C16.320.400.540 myotonia congenita 17
C16.320.400.542 myotonická dystrofie 94
C16.320.400.550 choreoakantocytóza 6
C16.320.400.560 neurofibromatózy 28
C16.320.400.820 Tourettův syndrom 86
C16.320.400.880 tuberózní skleróza 141